Cargando…
Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome
SIMPLE SUMMARY: Sézary syndrome (SS) is a leukemic and incurable variant of cutaneous T-cell lymphoma characterized by the accumulation of neoplastic CD4+ lymphocytes in the blood, lymph nodes, and skin. With the exception of allogenic transplantation, no curative chance is available to treat SS, an...
Autores principales: | Cristofoletti, Cristina, Bresin, Antonella, Fioretti, Martina, Russo, Giandomenico, Narducci, Maria Grazia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221051/ https://www.ncbi.nlm.nih.gov/pubmed/35740513 http://dx.doi.org/10.3390/cancers14122847 |
Ejemplares similares
-
Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome
por: Caprini, Elisabetta, et al.
Publicado: (2018) -
Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance
por: Cristofoletti, Cristina, et al.
Publicado: (2018) -
T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1
por: Bresin, Antonella, et al.
Publicado: (2018) -
CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome
por: Vergnolle, Inès, et al.
Publicado: (2022) -
Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab
por: Narducci, Maria Grazia, et al.
Publicado: (2020)